EMA launches investigation of contaminated valsartan products

The carcinogen NDMA has been detected in the valsartan active substance manufactured by Zhejiang Huahai Pharmaceuticals.
The carcinogen NDMA has been detected in the valsartan active substance manufactured by Zhejiang Huahai Pharmaceuticals.